Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 2

Sponsor Class

NETWORK 3OTHER_GOV 2

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Sarcoma 2Gynecologic 1Gastrointestinal 1

Conditions

Sarcoma 2Neoplasm Metastasis 1Colorectal Neoplasms 1

Interventions

Doxorubicin 3High-Throughput Nucleotide Sequencing 2Base Sequence 2trametinib 1spartalizumab 1ribociclib 1pembrolizumab 1palbociclib 1olaparib 1nilotinib 1ipatasertib 1glasdegib 1futibatinib 1durvalumab 1dactolisib 1dabrafenib 1ceritinib 1capmatinib 1camrelizumab 1apatinib 1anlotinib 1Zoledronic Acid 1Valganciclovir 1Transplantation, Homologous 1Transplantation, Autologous 1Rituximab 1Radiotherapy 1Psychoanalysis 1Nivolumab 1Lapatinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER_GOV × Base Sequence × Sarcoma × Clear all
NCT03784014 2026-04-29

MULTISARC

Institut National de la Santé Et de la Recherche Médicale, France

Phase 3 Completed
603 enrolled
Sarcoma

Neoplasm Metastasis, Sarcoma

NCT03546127 2025-09-11

MULTIPLI-0

Institut National de la Santé Et de la Recherche Médicale, France

Completed
24 enrolled
GastrointestinalSarcoma

Sarcoma, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡